Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.
2.

A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis.

Stover CK, Warrener P, VanDevanter DR, Sherman DR, Arain TM, Langhorne MH, Anderson SW, Towell JA, Yuan Y, McMurray DN, Kreiswirth BN, Barry CE, Baker WR.

Nature. 2000 Jun 22;405(6789):962-6.

PMID:
10879539
3.

Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments.

Coulter SN, Schwan WR, Ng EY, Langhorne MH, Ritchie HD, Westbrock-Wadman S, Hufnagle WO, Folger KR, Bayer AS, Stover CK.

Mol Microbiol. 1998 Oct;30(2):393-404.

4.

Identification and characterization of the PutP proline permease that contributes to in vivo survival of Staphylococcus aureus in animal models.

Schwan WR, Coulter SN, Ng EY, Langhorne MH, Ritchie HD, Brody LL, Westbrock-Wadman S, Bayer AS, Folger KR, Stover CK.

Infect Immun. 1998 Feb;66(2):567-72.

5.

Luciferase in vivo expression technology: use of recombinant mycobacterial reporter strains to evaluate antimycobacterial activity in mice.

Hickey MJ, Arain TM, Shawar RM, Humble DJ, Langhorne MH, Morgenroth JN, Stover CK.

Antimicrob Agents Chemother. 1996 Feb;40(2):400-7.

Supplemental Content

Loading ...
Support Center